Table 3. Clinical and demographic characteristics of liver waitlist candidates from bypass match runs, control match runs, and matched waitlist controls.
| Variable | Bypassed liver waitlist candidates, N=268 | Matched candidate approach | Matched allograft approach | |
|---|---|---|---|---|
|
| ||||
| Matched by match MELD score, N=2,144 | Matched by laboratory MELD score, N=2,340 | Liver candidates from control match runs, N=20,694 | ||
| Male gender, N (%) | 185 (69.0) | 1,442 (67.3) | 1,486 (63.5) | 13,109 (63.4) |
| Age at bypass or matching, median (IQR) | 56.9 (50.7,61.5) | 55.2 (49.0,60.3) | 55.2 (49.4, 61.1) | 55.7 (49.2,61.0) |
| Race/ethnicity, N (%) | ||||
| White | 189 (70.5) | 1,518 (70.8) | 1,7960 (75.2) | 14,481 (70.0) |
| Black | 28 (10.5) | 260 (12.1) | 236 (10.1) | 2,139 (10.3) |
| Hispanic | 32 (11.9) | 258 (12.0) | 246 (10.6) | 2,868 (13.9) |
| Asian | 12 (4.5) | 85 (4.0) | 82 (3.5) | 961 (4.6) |
| Other | 7 (2.6) | 23 (1.1) | 16 (0.7) | 245 (1.2) |
| Primary diagnosis, N (%) | ||||
| Hepatitis C | 93 (34.7) | 839 (39.1) | 852 (36.4) | 8,948 (43.2) |
| Alcohol | 34 (12.7) | 370 (17.3) | 429 (18.4) | 2,686 (13.0) |
| Hepatitis B | 2 (0.8) | 28 (2.7) | 61 (2.6) | 571 (2.8) |
| NASH/Cryptogenic | 30 (11.2) | 269 (12.6) | 338 (14.4) | 2,840 (13.7) |
| Cholestatic | 16 (6.0) | 161 (7.5) | 204 (8.7) | 1,492 (7.2) |
| Autoimmune | 8 (3.0) | 105 (4.9) | 122 (5.2) | 946 (4.6) |
| Fulminant hepatic failure | 18 (6.7) | 64 (3.0) | 313 (13.4) | 1,087 (5.3) |
| Other | 67 (25.0) | 278 (13.0) | 21 (0.9) | 2,124 (10.3) |
| Received exception points | 117 (43.7) | 426 (19.9) | 308 (13.2) | 5,929 (28.7) |